1. Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetes. Issue 4 (August 2021) Authors: Erdem, Neslihan; Montero, Enrique; Roep, Bart O. Journal: Current opinion in endocrinology, diabetes and obesity Issue: Volume 28:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Defining a cure for type 1 diabetes: a call to action. Issue 9 (September 2021) Authors: Roep, Bart O; Montero, Enrique; van Tienhoven, René; Atkinson, Mark A; Schatz, Desmond A; Mathieu, Chantal Journal: Lancet Issue: Volume 9:Issue 9(2021) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study. Issue 4 (April 2016) Authors: Chopra, Arvind; Chandrashekara, S.; Iyer, Rajgopalan; Rajasekhar, Liza; Shetty, Naresh; Veeravalli, Sarathchandra; Ghosh, Alakendu; Merchant, Mrugank; Oak, Jyotsna; Londhey, Vikram; Barve, Abhijit; Ramakrishnan, M.; Montero, Enrique Journal: Clinical rheumatology Issue: Volume 35:Issue 4(2016) Page Start: 1059 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases. (27th December 2010) Authors: Alonso-Ramirez, Ruby; Loisel, Séverine; Buors, Caroline; Pers, Jacques-Olivier; Montero, Enrique; Youinou, Pierre; Renaudineau, Yves Other Names: Chang Deh-Ming Academic Editor. Journal: Arthritis Issue: Volume 2010(2010) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗